天華新能(300390.SZ):子公司與Ford Motor簽署氫氧化鋰承購協議
格隆匯3月31日丨天華新能(300390.SZ)公佈,公司子公司宜賓市天宜鋰業科創有限公司(簡稱“天宜鋰業”)、四川天華時代鋰能有限公司(簡稱“四川天華”)(天宜鋰業和四川天華以下合稱“賣方”)與Ford Motor Company簽署了《氫氧化鋰承購協議》,協議雙方本着友好合作、平等自願的原則就氫氧化鋰產品的購銷事宜協商一致,建立合作關係。賣方2025年-2029年出售氫氧化鋰的總數量合計72,500±10%公噸,具體供應數量以雙方另行簽署的採購訂單為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.